What is the dosage and treatment duration for doxycycline (Doxycycline monohydrate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Monohydrate Dosage and Treatment Duration

The standard dosage for doxycycline monohydrate is 100 mg twice daily (200 mg on the first day followed by 100 mg twice daily) with treatment duration typically ranging from 7-21 days depending on the specific infection being treated. 1

Standard Adult Dosing

  • Initial dose: 200 mg on first day (administered as 100 mg every 12 hours)
  • Maintenance dose: 100 mg daily, either as a single dose or divided into two doses
  • For severe infections: 100 mg every 12 hours is recommended 1

Infection-Specific Dosing and Duration

Sexually Transmitted Infections

  • Chlamydia: 100 mg twice daily for 7 days 2
  • Nongonococcal urethritis: 100 mg twice daily for 7 days 2, 1
  • Uncomplicated gonococcal infections: 100 mg twice daily for 7 days 1
    • Alternative single-visit dose: 300 mg followed by another 300 mg one hour later

Tick-Borne Diseases

  • Human Granulocytic Anaplasmosis: 100 mg twice daily for 10 days 2
  • Lyme disease treatment: 100 mg twice daily for 10-21 days 2
  • Lyme disease prophylaxis: 200 mg single dose 2

Skin and Soft Tissue Infections

  • MRSA skin infections: 100 mg twice daily for 5-10 days 2

Sexually Transmitted Infections

  • Syphilis (early): 100 mg twice daily for 2 weeks (for penicillin-allergic patients) 1
  • Syphilis (>1 year duration): 100 mg twice daily for 4 weeks (for penicillin-allergic patients) 1
  • Acute epididymo-orchitis: 100 mg twice daily for at least 10 days 1

Prophylaxis

  • Malaria prophylaxis: 100 mg daily, beginning 1-2 days before travel and continuing for 4 weeks after leaving malarious area 1
  • Inhalational anthrax (post-exposure): 100 mg twice daily for 60 days 1

Special Considerations

Administration Guidelines

  • Take with adequate fluids to reduce risk of esophageal irritation 1
  • Can be taken with food or milk if gastric irritation occurs 1
  • The absorption is not markedly influenced by simultaneous food or milk intake 1

Efficacy Considerations

  • Doxycycline has excellent tissue penetration, reaching therapeutic levels in most organs including the respiratory tract, genitourinary system, and soft tissues 3
  • For respiratory tract infections, improvement typically occurs by the third to fifth day of treatment 4
  • In a clinical trial for respiratory infections, 87% of patients achieved good or very good results with the standard dosing regimen 4

Renal Impairment

  • No dosage adjustment needed in patients with renal impairment 1, 3
  • Does not accumulate in renal insufficiency and is not significantly removed during hemodialysis 3

Potential Pitfalls and Caveats

  • Side effects: Common side effects include nausea, vomiting, diarrhea, esophageal irritation, photosensitivity, and vaginal yeast infections 2
  • Contraindications: Should not be used in pregnant or nursing women (pregnancy category D), children under 8 years of age, or individuals with known hypersensitivity to tetracyclines 5
  • Drug interactions: Avoid taking within 2 hours of antacids, dairy products, or supplements containing calcium, magnesium, aluminum, iron, or zinc 2
  • Compliance considerations: Once-daily dosing may be possible for some infections due to doxycycline's prolonged half-life, potentially improving treatment compliance 3

For brucellosis treatment, doxycycline is typically combined with other agents, though monotherapy with doxycycline (100 mg twice daily for six weeks) has shown similar relapse rates to combination therapy in some studies 6.

References

Guideline

Management of Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Doxycycline.

Therapeutic drug monitoring, 1982

Research

Update on rosacea and anti-inflammatory-dose doxycycline.

Drugs of today (Barcelona, Spain : 1998), 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.